Global Closed System Transfer Device Market Insights and Forecast to 2028

Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Market Analysis and Insights: Global Closed System Transfer Device Market
Due to the COVID-19 pandemic, the global Closed System Transfer Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Closed Vial Access Devices accounting for % of the Closed System Transfer Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Closed System Transfer Device market size is valued at US$ million in 2021, while the US and Europe Closed System Transfer Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Closed System Transfer Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Closed System Transfer Device include BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Closed System Transfer Device Scope and Segment
Closed System Transfer Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Closed System Transfer Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segment by Application
Hospital
Clinic
By Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
B. Braun
By Region
North America
U.S.
Canada
Europe
Germany
Sweden
France
Finland
Spain
Asia-Pacific
China
Japan
India
Southeast Asia
Australia
Latin America
Mexico
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions